A decade of data discloses the window is still not clear.
- 1 January 2014
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 41 (1), 1-2
- https://doi.org/10.3899/jrheum.131116
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Longterm Effect of Delaying Combination Therapy with Tumor Necrosis Factor Inhibitor in Patients with Aggressive Early Rheumatoid Arthritis: 10-year Efficacy and Safety of Adalimumab from the Randomized Controlled PREMIER Trial with Open-label ExtensionThe Journal of Rheumatology, 2013
- OP0091 What is the Evidence for the Presence of a Therapeutic Window of Opportunity in Rheumatoid Arthritis? A Systematic Literature ReviewAnnals Of The Rheumatic Diseases, 2013
- Methodological aspects and the interpretation of clinical trial data: lessons from the TEAR trialRheumatology, 2012
- Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's diseaseAnnals Of The Rheumatic Diseases, 2012
- Reporting of long-term extension studies: lack of consistency calls for consensusAnnals Of The Rheumatic Diseases, 2011
- Altered expression of microRNA‐203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activationArthritis & Rheumatism, 2010
- The Michael Mason prize: early rheumatoid arthritis--the window narrowsRheumatology, 2009
- The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatmentArthritis & Rheumatism, 2005
- Understanding the window of opportunity concept in early rheumatoid arthritisArthritis & Rheumatism, 2003
- Treating rheumatoid arthritis early: A window of opportunity?Arthritis & Rheumatism, 2002